|
ZFP36L1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
2.840400E-02 |
| Normal-vs-Stage3 |
5.28455057491328E-12 |
| Normal-vs-Stage4 |
5.59829960167235E-10 |
| Stage1-vs-Stage2 |
1.856690E-03 |
| Stage1-vs-Stage3 |
4.648800E-01 |
| Stage1-vs-Stage4 |
4.337600E-01 |
| Stage2-vs-Stage3 |
5.619000E-03 |
| Stage2-vs-Stage4 |
1.115320E-03 |
| Stage3-vs-Stage4 |
1.762410E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
4.16189999999927E-05 |
| Normal-vs-Asian |
6.3038999997822E-07 |
| Caucasian-vs-AfricanAmerican |
3.257000E-01 |
| Caucasian-vs-Asian |
9.750200E-01 |
| AfricanAmerican-vs-Asian |
4.297800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.17759998921707E-09 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
6.869600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(41-60Yrs) |
1.88060678141255E-12 |
| Normal-vs-Age(61-80Yrs) |
1.33530000001603E-06 |
| Normal-vs-Age(81-100Yrs) |
3.195700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.522000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.234800E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.430000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.787800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.958800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.236400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.941600E-01 |
| Classical-VS-Follicular |
1.62447832963153E-12 |
| Classical-VS-Other |
5.423800E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
1.36469724409949E-11 |
| Tall-VS-Other |
6.181600E-01 |
| Tall-VS-Normal |
1.67321712041257E-12 |
| Follicular-VS-Other |
3.322900E-03 |
| Follicular-VS-Normal |
4.171200E-01 |
| Other-VS-Normal |
3.587600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.82179995720378E-09 |
| Normal-vs-N1 |
2.30449992422166E-10 |
| N0-vs-N1 |
8.21840000000407E-05 |
|
|
